Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600124292Phase 4Not yet recruiting
Phase 4, randomised trial of midazolam in inguinal hernia (2 arms), sponsored by Meishan City People's Hospital. Primary endpoint: Modified Yale Preoperative Anxiety Scale (m-YPAS) score. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600124292.